- Trade Names: Apekumarol; Dicumarol; Dicumol; Embolin
- Indications: Atrial fibrillation, pulmonary embolism, venous thrombosis
- Class: Coumarin
- Half-life: 1–4 days
- Clinically important, potentially hazardous interactions with:
Allopurinol, Amiodarone, Amobarbital, Anabolic steroids, Anti-thyroid agents, Aprobarbital, Aspirin, Barbiturates, Bivalirudin, Butabarbital, Butalbital, Cimetidine, Clofibrate, Clopidogrel, Cyclosporine, Delavirdine, Disulfiram, Fenofibrate, Fluconazole, Gemfibrozil, Glutethimide, Imatinib, Itraconazole, Ketoconazole, Levothyroxine, Liothyronine, Mephobarbital, Methimazole, Metronidazole, Miconazole, Penicillins, Pentobarbital, Phenobarbital, Phenylbutazones, Piperacillin, Prednisone, Primidone, Propylthiouracil, Quinidine, Quinine, Rifabutin, Rifampin, Rifapentine, Rofecoxib, Salicylates, Secobarbital, Sulfinpyrazone, Sulfonamides, Testosterone, Zileuton
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
